hypervolemic

Vaprisol is approved by the FDA for treatment of euvolemic and more recently hypervolemic hyponatremia and is given IV.

Can we believe guidelines formulated by "expert panels" james gaulte 2009

Vaprisol is approved by the FDA for treatment of euvolemic and more recently hypervolemic hyponatremia and is given IV.

Archive 2009-02-01 james gaulte 2009

People at highest risk of acute phosphate nephropathy are those over the age of 55, those who are hypervolemic or suffer from decreased intravascular volume, those who have baseline kidney disease, bowel obstruction or active colitis, and those who are taking medications that affect renal function.

Lawyers and Settlements :: Latest Cases & Settlements 2009

Vaprisol is indicated for the treatment of euvolemic and hypervolemic hyponatremia in hospitalized patients.

unknown title 2009

Furthermore, in contrast to patients with a low ejection fraction, patients with a normal ejection fraction could be hypovolemic (low blood volume), normovolemic (normal blood volume), or hypervolemic (high blood volume).

Marketwire - Breaking News Releases 2008

(low blood volume), normovolemic (normal blood volume), or hypervolemic (high blood volume).

Health News from Medical News Today 2008

Dilutional hyponatremia, which includes euvolemic and hypervolemic hyponatremia, is the most common form of the condition, and occurs when retained water dilutes serum sodium content. (

unknown title 2009

Vaprisol is the first AVP receptor antagonist with a demonstrated safety profile and that effectively promotes aquaresis in order to help restore salt and water balance in patients with euvolemic and hypervolemic hyponatremia. (

unknown title 2009

Discovered and developed by Astellas, Vaprisol, an arginine vasopressin (AVP) receptor antagonist, is the first and only approved drug indicated for the treatment of both euvolemic and hypervolemic hyponatremia in hospitalized patients. (

unknown title 2009